We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
+4.87%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$26.9B
AUM Growth
+$133M
Cap. Flow
-$722M
Cap. Flow %
-2.68%
Top 10 Hldgs %
41.71%
Holding
1,213
New
133
Increased
618
Reduced
406
Closed
45

Top Buys

Rank Stock Value
1
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$383M
2
AMAT icon
Applied Materials
AMAT
+$129M
3
NVDA icon
NVIDIA
NVDA
+$85M
4
FXI icon
iShares China Large-Cap ETF
FXI
+$42.8M
5
AMD icon
Advanced Micro Devices
AMD
+$40.4M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$383M
2
QCOM icon
Qualcomm
QCOM
+$171M
3
MU icon
Micron Technology
MU
+$156M
4
AVGO icon
Broadcom
AVGO
+$94.3M
5
ADI icon
Analog Devices
ADI
+$90.9M

Sector Composition

Rank Sector Weight
1 Technology 46.91%
2 Financials 9.57%
3 Healthcare 5.39%
4 Consumer Discretionary 3.89%
5 Energy 2.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SM icon
401
SM Energy
SM
$7.58B
$5.38M 0.02%
124,383
+9,345
+8% +$459K
EEM icon
402
iShares MSCI Emerging Markets ETF
EEM
$28.6B
$5.32M 0.02%
124,810
+11,563
+10% +$485K
TXT icon
403
Textron
TXT
$15B
$5.28M 0.02%
61,548
-4,884
-7% -$435K
ENPH icon
404
Enphase Energy
ENPH
$4.94B
$5.23M 0.02%
52,446
+3,474
+7% +$405K
SRE icon
405
Sempra
SRE
$58.6B
$5.22M 0.02%
68,651
-3,755
-5% -$278K
UBSI icon
406
United Bankshares
UBSI
$6.62B
$5.21M 0.02%
160,608
+8,506
+6% +$281K
RARE icon
407
Ultragenyx Pharmaceutical
RARE
$2.56B
$5.19M 0.02%
126,159
-55,325
-30% -$2.36M
DYN icon
408
Dyne Therapeutics
DYN
$4.8B
$5.13M 0.02%
145,378
-199,013
-58% -$5.78M
KEY icon
409
KeyCorp
KEY
$24.2B
$5.08M 0.02%
357,496
-10,956
-3% -$159K
TWST icon
410
Twist Bioscience
TWST
$5.69B
$5.08M 0.02%
103,077
-141,015
-58% -$5.75M
FBP icon
411
First Bancorp
FBP
$4.4B
$5.08M 0.02%
277,480
+2,310
+0.8% +$40.4K
JNPR
412
DELISTED
Juniper Networks
JNPR
$5.05M 0.02%
138,396
-8,147
-6% -$289K
NTLA icon
413
Intellia Therapeutics
NTLA
$1.55B
$5.04M 0.02%
225,212
-98,349
-30% -$2.34M
CRNX icon
414
Crinetics Pharmaceuticals
CRNX
$8.85B
$5.02M 0.02%
112,169
-104,680
-48% -$4.83M
HLT icon
415
Hilton Worldwide
HLT
$72.5B
$5.02M 0.02%
23,020
+190
+0.8% +$39K
EBAY icon
416
eBay
EBAY
$50.4B
$4.99M 0.02%
92,943
-3,649
-4% -$190K
ACAD icon
417
Acadia Pharmaceuticals
ACAD
$4.55B
$4.96M 0.02%
305,079
-86,146
-22% -$1.39M
JBL icon
418
Jabil
JBL
$32.3B
$4.95M 0.02%
45,489
+3,935
+9% +$477K
RNAM
419
DELISTED
Avidity Biosciences
RNAM
$4.92M 0.02%
120,557
-146,575
-55% -$4.21M
NUVL
420
DELISTED
Nuvalent
NUVL
$4.91M 0.02%
64,692
-43,976
-40% -$3.13M
HUM icon
421
Humana
HUM
$44B
$4.89M 0.02%
13,100
+469
+4% +$158K
CNX icon
422
CNX Resources
CNX
$4.9B
$4.89M 0.02%
201,094
-78,958
-28% -$1.93M
MMM icon
423
3M
MMM
$90.8B
$4.87M 0.02%
47,675
-7,294
-13% -$711K
NSC icon
424
Norfolk Southern
NSC
$75B
$4.86M 0.02%
22,640
+46
+0.2% +$10.7K
CARR icon
425
Carrier Global
CARR
$50.6B
$4.86M 0.02%
77,013
+7,536
+11% +$463K
15 16
17
18 19

Similar funds

CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Rafferty Asset Management's Q2 2024 Portfolio in Review

As of Q2 2024, Rafferty Asset Management held 1,213 positions worth $26.9B, up 0.5% from $26.8B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Rafferty Asset Management's Q2 2024 filing shows 133 new, 618 increased, 406 reduced and 45 closed positions. Its largest new stake was KKR & Co: 234,082 shares worth $24.6M. The largest sale was Apple, an estimated $383M.

By sector, the portfolio is most concentrated in Technology at 47% of assets, down from 47% a quarter earlier, followed by Financials and Healthcare.

  • Rafferty Asset Management's largest Q2 2024 buy was KKR & Co: 234,082 shares worth $24.6M.
  • Rafferty Asset Management added most to iShares 20+ Year Treasury Bond ETF in Q2 2024, an estimated $383M increase.
  • Rafferty Asset Management's biggest Q2 2024 reduction was Apple, cutting an estimated $383M.
  • Rafferty Asset Management fully exited iShares Core S&P Mid-Cap ETF in Q2 2024, selling an estimated $55.8M.
  • Rafferty Asset Management's ten largest holdings make up 42% of its $26.9B portfolio in Q2 2024.
  • Rafferty Asset Management opened 133 new positions and closed 45 in Q2 2024.
  • Rafferty Asset Management's portfolio value rose 0.5% quarter-over-quarter to $26.9B.

Based on Rafferty Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.